

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of skeletal muscle contraction (GO:0014819) | 4.96654744 |
| 2 | skeletal muscle contraction (GO:0003009) | 4.57202841 |
| 3 | positive regulation of protein kinase C signaling (GO:0090037) | 3.41832665 |
| 4 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.36517979 |
| 5 | positive regulation of defense response to virus by host (GO:0002230) | 3.24620183 |
| 6 | positive regulation of heat generation (GO:0031652) | 3.23845234 |
| 7 | NIK/NF-kappaB signaling (GO:0038061) | 3.19875860 |
| 8 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.09587581 |
| 9 | muscle filament sliding (GO:0030049) | 3.08336340 |
| 10 | actin-myosin filament sliding (GO:0033275) | 3.08336340 |
| 11 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.08128504 |
| 12 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.03109628 |
| 13 | negative regulation of cell killing (GO:0031342) | 3.03109628 |
| 14 | cellular response to ATP (GO:0071318) | 3.02714927 |
| 15 | cellular response to exogenous dsRNA (GO:0071360) | 3.02083612 |
| 16 | negative regulation of interleukin-12 production (GO:0032695) | 2.98923444 |
| 17 | immunoglobulin mediated immune response (GO:0016064) | 2.95092186 |
| 18 | mannose metabolic process (GO:0006013) | 2.91774651 |
| 19 | mature B cell differentiation involved in immune response (GO:0002313) | 2.90331191 |
| 20 | response to peptidoglycan (GO:0032494) | 2.87842571 |
| 21 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 2.82558786 |
| 22 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.79792400 |
| 23 | regulation of antigen processing and presentation (GO:0002577) | 2.77800789 |
| 24 | positive regulation of prostaglandin secretion (GO:0032308) | 2.73568613 |
| 25 | response to muramyl dipeptide (GO:0032495) | 2.73392538 |
| 26 | positive regulation of antigen processing and presentation (GO:0002579) | 2.72695583 |
| 27 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 2.70541717 |
| 28 | positive thymic T cell selection (GO:0045059) | 2.69079161 |
| 29 | germinal center formation (GO:0002467) | 2.67527494 |
| 30 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.67108689 |
| 31 | keratan sulfate catabolic process (GO:0042340) | 2.66519512 |
| 32 | regulation of chemokine biosynthetic process (GO:0045073) | 2.64991535 |
| 33 | tumor necrosis factor-mediated signaling pathway (GO:0033209) | 2.64758698 |
| 34 | negative regulation of granulocyte differentiation (GO:0030853) | 2.63515118 |
| 35 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.60033210 |
| 36 | positive regulation of histone deacetylation (GO:0031065) | 2.59925373 |
| 37 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.56398998 |
| 38 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.54873412 |
| 39 | response to interferon-beta (GO:0035456) | 2.54229893 |
| 40 | regulation of defense response to virus by host (GO:0050691) | 2.52030265 |
| 41 | GDP-mannose metabolic process (GO:0019673) | 2.47500393 |
| 42 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.45986772 |
| 43 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.45979904 |
| 44 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.45843064 |
| 45 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.45687449 |
| 46 | cellular response to interferon-beta (GO:0035458) | 2.44618715 |
| 47 | response to ATP (GO:0033198) | 2.44049081 |
| 48 | response to type I interferon (GO:0034340) | 2.43675312 |
| 49 | glycosphingolipid catabolic process (GO:0046479) | 2.42500268 |
| 50 | amino sugar catabolic process (GO:0046348) | 2.40842764 |
| 51 | T-helper cell differentiation (GO:0042093) | 2.40524721 |
| 52 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.40524721 |
| 53 | negative regulation of innate immune response (GO:0045824) | 2.39054649 |
| 54 | negative regulation of cell size (GO:0045792) | 2.38062240 |
| 55 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.37888582 |
| 56 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.37888582 |
| 57 | RNA destabilization (GO:0050779) | 2.37208894 |
| 58 | regulation of tumor necrosis factor superfamily cytokine production (GO:1903555) | 2.35996798 |
| 59 | cellular response to type I interferon (GO:0071357) | 2.35682269 |
| 60 | type I interferon signaling pathway (GO:0060337) | 2.35682269 |
| 61 | negative regulation of interleukin-8 production (GO:0032717) | 2.34528818 |
| 62 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.34201868 |
| 63 | regulation of interferon-alpha production (GO:0032647) | 2.33919980 |
| 64 | regulation of tumor necrosis factor production (GO:0032680) | 2.33016529 |
| 65 | tolerance induction (GO:0002507) | 2.32232656 |
| 66 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.32019608 |
| 67 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.31114898 |
| 68 | sphingolipid catabolic process (GO:0030149) | 2.30723729 |
| 69 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.29145349 |
| 70 | regulation of T-helper 1 type immune response (GO:0002825) | 2.27076709 |
| 71 | regulation of immunoglobulin secretion (GO:0051023) | 2.26217576 |
| 72 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.25726059 |
| 73 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.25345822 |
| 74 | myeloid dendritic cell differentiation (GO:0043011) | 2.25257584 |
| 75 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.24255942 |
| 76 | macrophage activation involved in immune response (GO:0002281) | 2.24163190 |
| 77 | positive regulation of myotube differentiation (GO:0010831) | 2.23289131 |
| 78 | actin-mediated cell contraction (GO:0070252) | 2.22848301 |
| 79 | membrane lipid catabolic process (GO:0046466) | 2.22710442 |
| 80 | regulation of chronic inflammatory response (GO:0002676) | 2.22512685 |
| 81 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.21407377 |
| 82 | regulation of interleukin-12 production (GO:0032655) | 2.21323281 |
| 83 | regulation of monocyte differentiation (GO:0045655) | 2.21079246 |
| 84 | regulation of memory T cell differentiation (GO:0043380) | 2.20096811 |
| 85 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.18947335 |
| 86 | positive regulation of protein deacetylation (GO:0090312) | 2.18574557 |
| 87 | glycolipid catabolic process (GO:0019377) | 2.18483284 |
| 88 | lysosome organization (GO:0007040) | 2.17631680 |
| 89 | lytic vacuole organization (GO:0080171) | 2.17631680 |
| 90 | lymphocyte chemotaxis (GO:0048247) | 2.17116860 |
| 91 | virion attachment to host cell (GO:0019062) | 2.17042673 |
| 92 | adhesion of symbiont to host cell (GO:0044650) | 2.17042673 |
| 93 | T-helper 1 type immune response (GO:0042088) | 2.16374631 |
| 94 | positive regulation of icosanoid secretion (GO:0032305) | 2.16327310 |
| 95 | oligosaccharide catabolic process (GO:0009313) | 2.15875339 |
| 96 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.14928162 |
| 97 | regulation of germinal center formation (GO:0002634) | 2.14913038 |
| 98 | negative regulation of T cell mediated immunity (GO:0002710) | 2.14418274 |
| 99 | ceramide catabolic process (GO:0046514) | 2.13828504 |
| 100 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.13506409 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.77704611 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.40119505 |
| 3 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.75690053 |
| 4 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.64225417 |
| 5 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.43978810 |
| 6 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.34063063 |
| 7 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.33363304 |
| 8 | P68_20966046_ChIP-Seq_HELA_Human | 2.09235516 |
| 9 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 2.07672200 |
| 10 | BCL6_27268052_Chip-Seq_Bcells_Human | 2.07365729 |
| 11 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.04342894 |
| 12 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.01323881 |
| 13 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.99276327 |
| 14 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.93617188 |
| 15 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.90202702 |
| 16 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.86077661 |
| 17 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.85802830 |
| 18 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.84004986 |
| 19 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.83481411 |
| 20 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.78689743 |
| 21 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.76799295 |
| 22 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.76082977 |
| 23 | MAF_26560356_Chip-Seq_TH2_Human | 1.73776029 |
| 24 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.71587892 |
| 25 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.70843577 |
| 26 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.70580083 |
| 27 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.69769281 |
| 28 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.69636132 |
| 29 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.68796808 |
| 30 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.57950274 |
| 31 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57389437 |
| 32 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.55402667 |
| 33 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.54413715 |
| 34 | SA1_27219007_Chip-Seq_Bcells_Human | 1.53018572 |
| 35 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.52837809 |
| 36 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.52218131 |
| 37 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.52154342 |
| 38 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.52112802 |
| 39 | MAF_26560356_Chip-Seq_TH1_Human | 1.51269618 |
| 40 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.50828828 |
| 41 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.50757607 |
| 42 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.50738887 |
| 43 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.50308398 |
| 44 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49496450 |
| 45 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.48083413 |
| 46 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.47127046 |
| 47 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.47104909 |
| 48 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.47097454 |
| 49 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.45176870 |
| 50 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.43263446 |
| 51 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.43131737 |
| 52 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.41531997 |
| 53 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.40706704 |
| 54 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.40289384 |
| 55 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39702452 |
| 56 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.39398614 |
| 57 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.39166017 |
| 58 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.38966590 |
| 59 | UTX_26944678_Chip-Seq_JUKART_Human | 1.38313955 |
| 60 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.38289736 |
| 61 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.37681306 |
| 62 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.36607212 |
| 63 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.36159869 |
| 64 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.34203212 |
| 65 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.33317247 |
| 66 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.33244598 |
| 67 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.31348550 |
| 68 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.30750158 |
| 69 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.30066481 |
| 70 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.29722271 |
| 71 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.29460759 |
| 72 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.27428597 |
| 73 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.26883661 |
| 74 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.25982261 |
| 75 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.23975823 |
| 76 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.20765748 |
| 77 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.20687386 |
| 78 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.20565164 |
| 79 | P300_27268052_Chip-Seq_Bcells_Human | 1.19871681 |
| 80 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.19220900 |
| 81 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18958633 |
| 82 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.16321494 |
| 83 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.16132498 |
| 84 | MYC_22102868_ChIP-Seq_BL_Human | 1.15622822 |
| 85 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.15590945 |
| 86 | * CTCF_20526341_ChIP-Seq_ESCs_Human | 1.14341272 |
| 87 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.13795032 |
| 88 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13191685 |
| 89 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.13143855 |
| 90 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.11025059 |
| 91 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.09036009 |
| 92 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.08872365 |
| 93 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.07555577 |
| 94 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06787273 |
| 95 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.05718319 |
| 96 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.03948623 |
| 97 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.03804225 |
| 98 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.03569145 |
| 99 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.03504855 |
| 100 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.02525284 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 3.80900174 |
| 2 | MP0003436_decreased_susceptibility_to | 3.15463381 |
| 3 | MP0005671_abnormal_response_to | 2.73568258 |
| 4 | MP0003303_peritoneal_inflammation | 2.58371120 |
| 5 | MP0002148_abnormal_hypersensitivity_rea | 2.55457289 |
| 6 | MP0001835_abnormal_antigen_presentation | 2.53853248 |
| 7 | MP0003724_increased_susceptibility_to | 2.53267925 |
| 8 | MP0009785_altered_susceptibility_to | 2.28460456 |
| 9 | MP0001790_abnormal_immune_system | 2.17771616 |
| 10 | MP0005387_immune_system_phenotype | 2.17771616 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.17300618 |
| 12 | MP0004510_myositis | 2.16642025 |
| 13 | MP0000685_abnormal_immune_system | 2.12741757 |
| 14 | MP0000751_myopathy | 2.12653537 |
| 15 | MP0002138_abnormal_hepatobiliary_system | 2.09615056 |
| 16 | MP0003172_abnormal_lysosome_physiology | 2.08033805 |
| 17 | MP0003279_aneurysm | 2.04533301 |
| 18 | MP0002419_abnormal_innate_immunity | 1.96649805 |
| 19 | MP0006082_CNS_inflammation | 1.96318740 |
| 20 | MP0002933_joint_inflammation | 1.91757712 |
| 21 | MP0005025_abnormal_response_to | 1.90622017 |
| 22 | MP0001533_abnormal_skeleton_physiology | 1.89023720 |
| 23 | MP0009840_abnormal_foam_cell | 1.87897045 |
| 24 | MP0002723_abnormal_immune_serum | 1.79447745 |
| 25 | MP0003806_abnormal_nucleotide_metabolis | 1.78291224 |
| 26 | MP0002837_dystrophic_cardiac_calcinosis | 1.78019905 |
| 27 | MP0000013_abnormal_adipose_tissue | 1.74344871 |
| 28 | MP0001800_abnormal_humoral_immune | 1.73193651 |
| 29 | MP0002254_reproductive_system_inflammat | 1.71998718 |
| 30 | MP0002452_abnormal_antigen_presenting | 1.71699267 |
| 31 | MP0002139_abnormal_hepatobiliary_system | 1.69503498 |
| 32 | MP0000750_abnormal_muscle_regeneration | 1.68950989 |
| 33 | MP0001542_abnormal_bone_strength | 1.63663507 |
| 34 | MP0001986_abnormal_taste_sensitivity | 1.62329479 |
| 35 | MP0000749_muscle_degeneration | 1.54901911 |
| 36 | MP0009333_abnormal_splenocyte_physiolog | 1.50178228 |
| 37 | MP0010155_abnormal_intestine_physiology | 1.49297430 |
| 38 | MP0001819_abnormal_immune_cell | 1.48014683 |
| 39 | MP0004145_abnormal_muscle_electrophysio | 1.47582261 |
| 40 | MP0004947_skin_inflammation | 1.45802489 |
| 41 | MP0001845_abnormal_inflammatory_respons | 1.44438250 |
| 42 | MP0002420_abnormal_adaptive_immunity | 1.43810536 |
| 43 | MP0005360_urolithiasis | 1.42474150 |
| 44 | MP0008438_abnormal_cutaneous_collagen | 1.40600110 |
| 45 | MP0009764_decreased_sensitivity_to | 1.40119793 |
| 46 | MP0005451_abnormal_body_composition | 1.40073588 |
| 47 | MP0008469_abnormal_protein_level | 1.39652497 |
| 48 | MP0000343_altered_response_to | 1.39364730 |
| 49 | MP0005167_abnormal_blood-brain_barrier | 1.36486307 |
| 50 | MP0009384_cardiac_valve_regurgitation | 1.35956364 |
| 51 | MP0002998_abnormal_bone_remodeling | 1.33251784 |
| 52 | MP0003075_altered_response_to | 1.29415751 |
| 53 | MP0004381_abnormal_hair_follicle | 1.25792942 |
| 54 | MP0009278_abnormal_bone_marrow | 1.22946936 |
| 55 | MP0002405_respiratory_system_inflammati | 1.20973489 |
| 56 | MP0000747_muscle_weakness | 1.20736049 |
| 57 | MP0000003_abnormal_adipose_tissue | 1.18771926 |
| 58 | MP0005390_skeleton_phenotype | 1.15613728 |
| 59 | MP0001873_stomach_inflammation | 1.13323832 |
| 60 | MP0003763_abnormal_thymus_physiology | 1.11169397 |
| 61 | MP0005166_decreased_susceptibility_to | 1.10763802 |
| 62 | MP0005330_cardiomyopathy | 1.10579033 |
| 63 | MP0002163_abnormal_gland_morphology | 1.08578961 |
| 64 | MP0001958_emphysema | 1.07596167 |
| 65 | MP0001853_heart_inflammation | 1.06464433 |
| 66 | MP0005174_abnormal_tail_pigmentation | 1.04534725 |
| 67 | MP0000604_amyloidosis | 1.03107146 |
| 68 | MP0003136_yellow_coat_color | 1.01075168 |
| 69 | MP0000716_abnormal_immune_system | 0.97247012 |
| 70 | MP0009643_abnormal_urine_homeostasis | 0.97076469 |
| 71 | MP0000759_abnormal_skeletal_muscle | 0.97009158 |
| 72 | MP0005365_abnormal_bile_salt | 0.96899278 |
| 73 | MP0001756_abnormal_urination | 0.93955803 |
| 74 | MP0004858_abnormal_nervous_system | 0.93771174 |
| 75 | MP0003191_abnormal_cellular_cholesterol | 0.93489788 |
| 76 | MP0000733_abnormal_muscle_development | 0.93081718 |
| 77 | MP0002106_abnormal_muscle_physiology | 0.89588768 |
| 78 | MP0003300_gastrointestinal_ulcer | 0.89253445 |
| 79 | MP0003866_abnormal_defecation | 0.88611757 |
| 80 | MP0005595_abnormal_vascular_smooth | 0.87216988 |
| 81 | MP0005319_abnormal_enzyme/_coenzyme | 0.86553113 |
| 82 | MP0003453_abnormal_keratinocyte_physiol | 0.86289655 |
| 83 | MP0005332_abnormal_amino_acid | 0.86116892 |
| 84 | MP0003195_calcinosis | 0.85456732 |
| 85 | MP0001243_abnormal_dermal_layer | 0.84832607 |
| 86 | MP0003879_abnormal_hair_cell | 0.83580484 |
| 87 | MP0006036_abnormal_mitochondrial_physio | 0.83417180 |
| 88 | MP0005379_endocrine/exocrine_gland_phen | 0.83013174 |
| 89 | MP0005375_adipose_tissue_phenotype | 0.82776678 |
| 90 | MP0004036_abnormal_muscle_relaxation | 0.81564793 |
| 91 | MP0003795_abnormal_bone_structure | 0.80117307 |
| 92 | MP0003045_fibrosis | 0.79475010 |
| 93 | MP0001765_abnormal_ion_homeostasis | 0.78877920 |
| 94 | MP0004087_abnormal_muscle_fiber | 0.78732187 |
| 95 | MP0008875_abnormal_xenobiotic_pharmacok | 0.78018350 |
| 96 | MP0002429_abnormal_blood_cell | 0.75456735 |
| 97 | MP0005165_increased_susceptibility_to | 0.75287952 |
| 98 | MP0003646_muscle_fatigue | 0.75099591 |
| 99 | MP0002136_abnormal_kidney_physiology | 0.73547055 |
| 100 | MP0006054_spinal_hemorrhage | 0.73300562 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Distal arthrogryposis (HP:0005684) | 7.11035132 |
| 2 | Round ear (HP:0100830) | 6.58666509 |
| 3 | Ulnar deviation of the wrist (HP:0003049) | 6.25189740 |
| 4 | Abnormality of glycolipid metabolism (HP:0010969) | 4.22631152 |
| 5 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.22631152 |
| 6 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.22631152 |
| 7 | Malignant hyperthermia (HP:0002047) | 3.75940502 |
| 8 | Fetal akinesia sequence (HP:0001989) | 3.67654537 |
| 9 | Calcaneovalgus deformity (HP:0001848) | 3.67369812 |
| 10 | Thin bony cortex (HP:0002753) | 3.62042203 |
| 11 | Absent phalangeal crease (HP:0006109) | 3.58738041 |
| 12 | Dysostosis multiplex (HP:0000943) | 3.57105785 |
| 13 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.35501640 |
| 14 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.35501640 |
| 15 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.35501640 |
| 16 | Trismus (HP:0000211) | 3.34279879 |
| 17 | Joint stiffness (HP:0001387) | 3.30680120 |
| 18 | Testicular atrophy (HP:0000029) | 3.29838325 |
| 19 | Deformed tarsal bones (HP:0008119) | 3.27886134 |
| 20 | Aplasia of the musculature (HP:0100854) | 3.27413734 |
| 21 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.14727415 |
| 22 | Mucopolysacchariduria (HP:0008155) | 3.14727415 |
| 23 | Popliteal pterygium (HP:0009756) | 3.10109913 |
| 24 | Vacuolated lymphocytes (HP:0001922) | 2.90753956 |
| 25 | Abnormal finger flexion creases (HP:0006143) | 2.85669313 |
| 26 | Myopathic facies (HP:0002058) | 2.83023329 |
| 27 | Asymmetric septal hypertrophy (HP:0001670) | 2.73797442 |
| 28 | Amniotic constriction ring (HP:0009775) | 2.73077277 |
| 29 | Abnormality of placental membranes (HP:0011409) | 2.73077277 |
| 30 | Systemic lupus erythematosus (HP:0002725) | 2.69684018 |
| 31 | Myositis (HP:0100614) | 2.67838616 |
| 32 | Nemaline bodies (HP:0003798) | 2.61133448 |
| 33 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.59108520 |
| 34 | Mesangial abnormality (HP:0001966) | 2.58995271 |
| 35 | J-shaped sella turcica (HP:0002680) | 2.46637610 |
| 36 | Increased cerebral lipofuscin (HP:0011813) | 2.43692655 |
| 37 | Akinesia (HP:0002304) | 2.40952307 |
| 38 | Optic neuritis (HP:0100653) | 2.38766400 |
| 39 | Retrobulbar optic neuritis (HP:0100654) | 2.38766400 |
| 40 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.37481642 |
| 41 | Loss of speech (HP:0002371) | 2.37108904 |
| 42 | Bulbar palsy (HP:0001283) | 2.36802038 |
| 43 | Orchitis (HP:0100796) | 2.35101036 |
| 44 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.31332460 |
| 45 | Type 1 muscle fiber predominance (HP:0003803) | 2.27214660 |
| 46 | Neoplasm of the heart (HP:0100544) | 2.22721750 |
| 47 | Facial diplegia (HP:0001349) | 2.21432399 |
| 48 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.19722140 |
| 49 | Stomatitis (HP:0010280) | 2.18989215 |
| 50 | Muscle fiber inclusion bodies (HP:0100299) | 2.18277991 |
| 51 | Prolonged neonatal jaundice (HP:0006579) | 2.17548548 |
| 52 | Hemoptysis (HP:0002105) | 2.15738668 |
| 53 | Enlarged epiphyses (HP:0010580) | 2.15107283 |
| 54 | Stridor (HP:0010307) | 2.13138677 |
| 55 | Breech presentation (HP:0001623) | 2.11936170 |
| 56 | Exercise-induced myalgia (HP:0003738) | 2.11217367 |
| 57 | Recurrent bacterial skin infections (HP:0005406) | 2.09312357 |
| 58 | Eczematoid dermatitis (HP:0000976) | 2.08261685 |
| 59 | Increased serum ferritin (HP:0003281) | 2.06713806 |
| 60 | Cervical subluxation (HP:0003308) | 2.06426326 |
| 61 | Type 2 muscle fiber atrophy (HP:0003554) | 2.03926544 |
| 62 | Muscle fiber atrophy (HP:0100295) | 1.99399253 |
| 63 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 1.98215704 |
| 64 | Recurrent abscess formation (HP:0002722) | 1.97959361 |
| 65 | Gastrointestinal infarctions (HP:0005244) | 1.96306554 |
| 66 | Metatarsus adductus (HP:0001840) | 1.95907699 |
| 67 | Nuclear cataract (HP:0100018) | 1.95831709 |
| 68 | Pulmonary infiltrates (HP:0002113) | 1.94000711 |
| 69 | Hip contracture (HP:0003273) | 1.93612679 |
| 70 | Hematochezia (HP:0002573) | 1.93206091 |
| 71 | Abnormality of macrophages (HP:0004311) | 1.91735536 |
| 72 | Pustule (HP:0200039) | 1.85534899 |
| 73 | Recurrent cutaneous fungal infections (HP:0011370) | 1.82699575 |
| 74 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.82699575 |
| 75 | Recurrent fungal infections (HP:0002841) | 1.81990556 |
| 76 | Rib fusion (HP:0000902) | 1.80740005 |
| 77 | Delayed epiphyseal ossification (HP:0002663) | 1.79608332 |
| 78 | Abnormality of the calcaneus (HP:0008364) | 1.76988693 |
| 79 | Easy fatigability (HP:0003388) | 1.76744709 |
| 80 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.73160319 |
| 81 | Increased muscle lipid content (HP:0009058) | 1.72859825 |
| 82 | Dicarboxylic aciduria (HP:0003215) | 1.72343802 |
| 83 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.72343802 |
| 84 | Abnormality of the costochondral junction (HP:0000919) | 1.70756153 |
| 85 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 1.70257241 |
| 86 | Hypoplastic heart (HP:0001961) | 1.69688663 |
| 87 | Progressive neurologic deterioration (HP:0002344) | 1.68593347 |
| 88 | Colitis (HP:0002583) | 1.68523874 |
| 89 | Abnormality of the neuromuscular junction (HP:0003398) | 1.66817494 |
| 90 | Fatigable weakness (HP:0003473) | 1.66817494 |
| 91 | Emphysema (HP:0002097) | 1.66627441 |
| 92 | Recurrent skin infections (HP:0001581) | 1.65904746 |
| 93 | Muscle fiber splitting (HP:0003555) | 1.64573493 |
| 94 | Petechiae (HP:0000967) | 1.64562518 |
| 95 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.64311707 |
| 96 | Abnormality of iron homeostasis (HP:0011031) | 1.63220594 |
| 97 | Mediastinal lymphadenopathy (HP:0100721) | 1.60956925 |
| 98 | Hepatocellular necrosis (HP:0001404) | 1.59193262 |
| 99 | Mitochondrial inheritance (HP:0001427) | 1.58418722 |
| 100 | Autoimmune thrombocytopenia (HP:0001973) | 1.56730654 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TLK1 | 2.80973256 |
| 2 | TXK | 2.76434492 |
| 3 | MAPK15 | 2.55916123 |
| 4 | TBK1 | 2.39608501 |
| 5 | MAP4K1 | 2.39127636 |
| 6 | NME2 | 2.39106441 |
| 7 | MAP3K14 | 2.36410319 |
| 8 | TRIB3 | 2.28212905 |
| 9 | BLK | 2.14278307 |
| 10 | TNK2 | 2.10233717 |
| 11 | IRAK3 | 1.97083670 |
| 12 | ERN1 | 1.91261251 |
| 13 | MAP2K6 | 1.90743020 |
| 14 | IKBKB | 1.86591095 |
| 15 | MAPKAPK3 | 1.85326979 |
| 16 | SMG1 | 1.85117918 |
| 17 | MUSK | 1.69987312 |
| 18 | GRK6 | 1.64196132 |
| 19 | SIK1 | 1.63809507 |
| 20 | KDR | 1.62931880 |
| 21 | PRKD3 | 1.56835416 |
| 22 | ZAP70 | 1.54832425 |
| 23 | DDR2 | 1.53952303 |
| 24 | RIPK4 | 1.53761740 |
| 25 | IKBKE | 1.53216418 |
| 26 | PRKD2 | 1.52374103 |
| 27 | VRK2 | 1.52273313 |
| 28 | MAP3K11 | 1.49102828 |
| 29 | TYK2 | 1.48845467 |
| 30 | MAP2K3 | 1.48455738 |
| 31 | KIT | 1.48399696 |
| 32 | MAP3K13 | 1.40105032 |
| 33 | FES | 1.34813120 |
| 34 | ADRBK2 | 1.31605851 |
| 35 | MAP2K2 | 1.30699134 |
| 36 | IRAK4 | 1.20954978 |
| 37 | PIK3CG | 1.19209028 |
| 38 | TESK2 | 1.15705791 |
| 39 | WNK4 | 1.14625020 |
| 40 | JAK3 | 1.10091780 |
| 41 | TAOK3 | 1.09148187 |
| 42 | CHUK | 1.08019405 |
| 43 | EPHB1 | 1.06615958 |
| 44 | GRK7 | 1.05089408 |
| 45 | BCKDK | 1.04088264 |
| 46 | SYK | 1.00024073 |
| 47 | STK16 | 0.99694703 |
| 48 | MOS | 0.98285758 |
| 49 | CSK | 0.96776525 |
| 50 | TGFBR2 | 0.96397290 |
| 51 | MAPK7 | 0.96373933 |
| 52 | TAOK2 | 0.96220487 |
| 53 | BTK | 0.94016544 |
| 54 | PIM2 | 0.94001463 |
| 55 | MAPK12 | 0.90259382 |
| 56 | SIK2 | 0.90038551 |
| 57 | MAP3K7 | 0.89064551 |
| 58 | TESK1 | 0.87607355 |
| 59 | OBSCN | 0.87537049 |
| 60 | ABL2 | 0.83869742 |
| 61 | NUAK1 | 0.82995232 |
| 62 | PHKG2 | 0.82176771 |
| 63 | PHKG1 | 0.82176771 |
| 64 | ITK | 0.81380122 |
| 65 | CDC42BPA | 0.80260523 |
| 66 | RPS6KA2 | 0.78688718 |
| 67 | CSF1R | 0.76792520 |
| 68 | MATK | 0.76418852 |
| 69 | NME1 | 0.76356214 |
| 70 | LYN | 0.76092990 |
| 71 | MAP3K3 | 0.76026112 |
| 72 | FGFR4 | 0.75466959 |
| 73 | RPS6KC1 | 0.68872266 |
| 74 | RPS6KL1 | 0.68872266 |
| 75 | HIPK2 | 0.68825237 |
| 76 | MARK2 | 0.66882012 |
| 77 | RIPK1 | 0.66107175 |
| 78 | DAPK3 | 0.65096325 |
| 79 | DAPK2 | 0.65078213 |
| 80 | RPS6KA6 | 0.63210629 |
| 81 | JAK1 | 0.62288823 |
| 82 | PDPK1 | 0.61222207 |
| 83 | LCK | 0.60814726 |
| 84 | TRPM7 | 0.60187893 |
| 85 | HCK | 0.57781824 |
| 86 | TIE1 | 0.54896482 |
| 87 | DAPK1 | 0.53798324 |
| 88 | LIMK1 | 0.49733327 |
| 89 | MAP3K1 | 0.49096184 |
| 90 | MAPK11 | 0.47515329 |
| 91 | PDK1 | 0.46344521 |
| 92 | PRKAA2 | 0.46165173 |
| 93 | MAPKAPK2 | 0.46065584 |
| 94 | TEC | 0.45645711 |
| 95 | TAOK1 | 0.45474546 |
| 96 | MYLK | 0.45066532 |
| 97 | GRK1 | 0.43078669 |
| 98 | ILK | 0.42973726 |
| 99 | EPHA3 | 0.42882533 |
| 100 | MAPK4 | 0.38632010 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 4.36146291 |
| 2 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.60489264 |
| 3 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 3.07649939 |
| 4 | Asthma_Homo sapiens_hsa05310 | 3.03118558 |
| 5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.91980747 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 2.73807859 |
| 7 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.50075726 |
| 8 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.45147592 |
| 9 | Sulfur relay system_Homo sapiens_hsa04122 | 2.37834010 |
| 10 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.32371240 |
| 11 | Lysosome_Homo sapiens_hsa04142 | 2.31721518 |
| 12 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.19071412 |
| 13 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.14280067 |
| 14 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.11999570 |
| 15 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.08511377 |
| 16 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.02947083 |
| 17 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.02320870 |
| 18 | Leishmaniasis_Homo sapiens_hsa05140 | 1.98306370 |
| 19 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.84406283 |
| 20 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.63109912 |
| 21 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.56007916 |
| 22 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.51115502 |
| 23 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.46434861 |
| 24 | Pertussis_Homo sapiens_hsa05133 | 1.46016076 |
| 25 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.43556308 |
| 26 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.43095379 |
| 27 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.35521517 |
| 28 | Tuberculosis_Homo sapiens_hsa05152 | 1.31162836 |
| 29 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.28724061 |
| 30 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.27271261 |
| 31 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.27196978 |
| 32 | Malaria_Homo sapiens_hsa05144 | 1.25065358 |
| 33 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.23378048 |
| 34 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.19763995 |
| 35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.19351201 |
| 36 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.09502875 |
| 37 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.02161529 |
| 38 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.93283125 |
| 39 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.89696897 |
| 40 | Viral myocarditis_Homo sapiens_hsa05416 | 0.83073824 |
| 41 | Mineral absorption_Homo sapiens_hsa04978 | 0.79742258 |
| 42 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.78920459 |
| 43 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.78620342 |
| 44 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.77834937 |
| 45 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.77665552 |
| 46 | Influenza A_Homo sapiens_hsa05164 | 0.73884778 |
| 47 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.73684801 |
| 48 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.71312535 |
| 49 | Legionellosis_Homo sapiens_hsa05134 | 0.67245068 |
| 50 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.67158104 |
| 51 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.65386329 |
| 52 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.65374435 |
| 53 | Parkinsons disease_Homo sapiens_hsa05012 | 0.64759397 |
| 54 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.64462488 |
| 55 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.64453025 |
| 56 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.64024280 |
| 57 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.61413020 |
| 58 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.58126608 |
| 59 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.56611092 |
| 60 | Hepatitis C_Homo sapiens_hsa05160 | 0.56537175 |
| 61 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.55603326 |
| 62 | Alzheimers disease_Homo sapiens_hsa05010 | 0.55366824 |
| 63 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.54813314 |
| 64 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.54658418 |
| 65 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.51928941 |
| 66 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.50764663 |
| 67 | Phagosome_Homo sapiens_hsa04145 | 0.50751594 |
| 68 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.49426049 |
| 69 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.46794558 |
| 70 | Ribosome_Homo sapiens_hsa03010 | 0.46486975 |
| 71 | Measles_Homo sapiens_hsa05162 | 0.46430879 |
| 72 | Galactose metabolism_Homo sapiens_hsa00052 | 0.45778666 |
| 73 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.45644372 |
| 74 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.45606220 |
| 75 | Peroxisome_Homo sapiens_hsa04146 | 0.45385080 |
| 76 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.45028889 |
| 77 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.41805210 |
| 78 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.41600686 |
| 79 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.40826865 |
| 80 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.40390114 |
| 81 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.39976602 |
| 82 | Insulin resistance_Homo sapiens_hsa04931 | 0.39134383 |
| 83 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.37300028 |
| 84 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.36653563 |
| 85 | Salmonella infection_Homo sapiens_hsa05132 | 0.34338455 |
| 86 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.30825645 |
| 87 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.30339688 |
| 88 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.30269320 |
| 89 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.30031492 |
| 90 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.28600464 |
| 91 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.28542136 |
| 92 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.28152857 |
| 93 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.27900166 |
| 94 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.27792878 |
| 95 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.27537482 |
| 96 | Amoebiasis_Homo sapiens_hsa05146 | 0.27334075 |
| 97 | Shigellosis_Homo sapiens_hsa05131 | 0.25217454 |
| 98 | Phototransduction_Homo sapiens_hsa04744 | 0.24052876 |
| 99 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.22301865 |
| 100 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.21285648 |

